Rafael Amado, EVP of R&D and CMO at Allogene Therapeutics, Inc. (ALLO), sold 5,169 shares at $7.71 ($40K) on 2022-03-15, disclosed to the SEC on 2022-03-17.
Open-market sale of $40k ALLO by EVP of R&D and CMO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ZLAB | SELL | 2026-03-16 | $110K | — | Filing → |
| ZLAB | SELL | 2026-03-05 | $174K | — | Filing → |
| ZLAB | SELL | 2026-01-02 | $188K | — | Filing → |